Effectiveness of Point-of-Care High-Sensitivity Troponin Testing in the Emergency Department: A Randomized Controlled

Viola I L Thulin1, Silje M F Jordalen1, Gard M S Myrmel2

  • 1Emergency Care Clinic, Haukeland University Hospital, Bergen, Norway.

PubMed

Insights

Point-of-care high-sensitivity cardiac troponin (hs-cTn) testing in the emergency department did not significantly reduce patient length of stay. This diagnostic approach also showed no difference in major adverse cardiac events within 30 days.

Area of Science:

  • Emergency Medicine
  • Cardiology
  • Clinical Diagnostics

Background:

  • Acute coronary syndrome (ACS) requires rapid diagnosis in the emergency department (ED).
  • High-sensitivity cardiac troponin (hs-cTn) assays are crucial for ACS evaluation.
  • Point-of-care testing (POCT) offers potential for faster results compared to central laboratory analysis.

Purpose of the Study:

  • To compare the effectiveness of hs-cTn point-of-care testing (POCT) versus central laboratory measurements for ACS investigation in the ED.
  • To evaluate the impact of POCT on emergency department length of stay (LOS).

Main Methods:

  • A single-center prospective randomized controlled trial (WESTCOR study) was conducted.
  • Patients with possible ACS were randomized 1:1 to receive either 0/1-hour centralized hs-cTnT or 0/1-hour point-of-care hs-cTnI testing.
  • The primary endpoint was ED length of stay, with a minimum clinically meaningful difference set at 15 minutes.

Main Results:

  • 1,494 patients were analyzed; 728 in the POCT group and 766 in the control group.
  • Median ED LOS was 174 minutes for POCT versus 180 minutes for the control group, a non-significant reduction of 6 minutes.
  • Rates of acute myocardial infarction, death, or acute revascularization within 30 days were similar between groups (11.4% vs. 9.4%).

Conclusions:

  • Implementing point-of-care hs-cTnI testing with a 0/1-hour algorithm did not achieve a clinically meaningful reduction in ED LOS.
  • No significant difference in major adverse cardiac events was observed between POCT and central laboratory testing during 30-day follow-up.
Abstract